VRCA — Verrica Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall CapNeutral
- $191.91m
- $152.46m
- $12.00m
Annual balance sheet for Verrica Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 8.66 | 89.8 | 62 | 65.5 | 70.4 |
| Prepaid Expenses | |||||
| Total Current Assets | 9.08 | 91.2 | 65 | 67.7 | 74.3 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0 | 0.255 | 2.2 | 4.94 | 5.5 |
| Other Long Term Assets | |||||
| Total Assets | 9.08 | 91.9 | 68.4 | 74.2 | 80.1 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.616 | 2.48 | 3.35 | 39.5 | 46.1 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.616 | 2.48 | 3.41 | 41.2 | 47.5 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 8.47 | 89.4 | 65 | 33 | 32.6 |
| Total Liabilities & Shareholders' Equity | 9.08 | 91.9 | 68.4 | 74.2 | 80.1 |
| Total Common Shares Outstanding |